THE INTERRELATIONSHIPS BETWEEN SERUM 25-HYDROXYCHOLECALCIFEROL, SERUM PARATHYROID HORMONE AND BONE CHANGES IN ANTICONVULSANT OSTEOMALACIA
- 1 March 1977
- journal article
- research article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 84 (3) , 559-565
- https://doi.org/10.1530/acta.0.0840559
Abstract
Serum 25-hydroxycholecalciferol (25-HCC) and serum parathyroid hormone (iPTH) were measured in 59 randomly selected adult epileptic outpatients receiving chronic anticonvulsant therapy. Quantitative morphometric analysis of iliac crest biopsies was performed. A mild degree of osteomalacia was found which was inversely correlated to dietary vitamin D intake. Serum 25-HCC was reduced in the epileptic patients compared to a control group, although dietary intake of vitamin D was higher than the mean daily intake in the Danish population. Serum 25-HCC was positively correlated to dietary vitamin D intake, but not correlated to the severity of bone changes, indicating that other factors than circulating 25-HCC are responsible for the development of anticonvulsant osteomalacia. Serum 25-HCG was inversely correlated to serum iPTH in patients with a low dietary calcium intake. The mean value of serum iPTH was not increased, and there was no correlation between serum iPTH and bone morphometry.This publication has 1 reference indexed in Scilit:
- A Sensitive Radioimmunoassay of Parathyroid Hormone in Human Serum Using a Specific Extraction ProcedureScandinavian Journal of Clinical and Laboratory Investigation, 1976